These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23823891)

  • 1. Dyslipidemia prevalence, treatment, control, and awareness in the Canadian Health Measures Survey.
    Joffres M; Shields M; Tremblay MS; Connor Gorber S
    Can J Public Health; 2013 Apr; 104(3):e252-7. PubMed ID: 23823891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.
    Janus ED; Tideman PA; Dunbar JA; Kilkkinen A; Bunker SJ; Philpot B; Tirimacco R; Mc Namara K; Heistaro S; Laatikainen T
    Med J Aust; 2010 Feb; 192(3):127-32. PubMed ID: 20121678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).
    Goodman SG; Langer A; Bastien NR; McPherson R; Francis GA; Genest JJ; Leiter LA;
    Can J Cardiol; 2010 Nov; 26(9):e330-5. PubMed ID: 21076724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
    Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
    Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population health impact of statin treatment in Canada.
    Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
    Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ; Merikle E; Jones J
    Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
    Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
    Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: the di@bet.es study.
    Martinez-Hervas S; Carmena R; Ascaso JF; Real JT; Masana L; Catalá M; Vendrell J; Vázquez JA; Valdés S; Urrutia I; Soriguer F; Serrano-Rios M; Rojo-Martínez G; Pascual-Manich G; Ortega E; Mora-Peces I; Menéndez E; Martínez-Larrad MT; López-Alba A; Gomis R; Goday A; Girbés J; Gaztambide S; Franch J; Delgado E; Castell C; Castaño L; Casamitjana R; Calle-Pascual A; Bordiú E
    Clin Investig Arterioscler; 2014; 26(3):107-14. PubMed ID: 24461346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary management of dyslipidemia in high-risk patients: targets still not met.
    Yan AT; Yan RT; Tan M; Hackam DG; Leblanc KL; Kertland H; Tsang JL; Jaffer S; Kates ML; Leiter LA; Fitchett DH; Langer A; Goodman SG;
    Am J Med; 2006 Aug; 119(8):676-83. PubMed ID: 16887414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
    Grover SA; Coupal L; Kaouache M; Lowensteyn I
    Can J Cardiol; 2007 May; 23(6):467-73. PubMed ID: 17487292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-year time-trend analysis of dyslipidemia among adults in Newfoundland and Labrador: findings from the laboratory information system between 2009 and 2014.
    Pedram P; Aref-Eshghi E; Mariathas HH; Hurley O; Godwin M; Duke P; Mahdavian M; Asghari S
    Lipids Health Dis; 2018 May; 17(1):99. PubMed ID: 29720176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
    He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
    Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China.
    Yan L; Xu MT; Yuan L; Chen B; Xu ZR; Guo QH; Li Q; Duan Y; Huang Fu J; Wang YJ; Zhang M; Luo ZJ; Zhao WG; Wang YM; Yuan ZF; Wang WQ; Wang PH; Ran XW; Wang YJ; Yang HZ; Gao L; Chen WQ; Ning G
    J Clin Lipidol; 2016; 10(1):150-60. PubMed ID: 26892132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study.
    Xing L; Jing L; Tian Y; Yan H; Zhang B; Sun Q; Dai D; Shi L; Liu D; Yang Z; Liu S
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2262-2270. PubMed ID: 32988725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China.
    Cai L; Zhang L; Liu A; Li S; Wang P
    J Atheroscler Thromb; 2012; 19(2):159-68. PubMed ID: 22041495
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.